Curident introduces a one-step soothing oral care solution for cancer patients

Curident, a company focused on patient-centered oral care innovation, today announced the national introduction of its patent-pending Curident oral care system. From the creators of ReadyBrush, this one-step disposable oral care solution is designed specifically for individuals undergoing cancer treatment and experiencing complications. 

Cancer treatments such as chemotherapy, radiation and stem cell transplantation often result in painful oral conditions that make daily hygiene difficult. Curident was developed to address this need with a simple, gentle approach to brushing when patients need it most.

Designed for Comfort, Safety and Simplicity

Curident’s unique design reflects the needs of both patients and healthcare professionals:

• Extra soft, feathered bristles for gentle, non-irritating brushing.
• Pre-pasted formula free from sodium lauryl sulfate (SLS) and mint flavoring.
• Tutti-frutti flavor to minimize irritation in sensitive mouths.
• Soothing ingredients, including aloe, chamomile, calendula and naturally derived agents.
• Hydroxyapatite to help support enamel and oral health.
• Single-use disposable format to promote hygiene and reduce bacterial exposure – especially important for immunocompromised individuals 

A Mission Rooted in Compassion

“Curident was created with one clear purpose — to provide comfort and restore dignity to patients facing the challenges of cancer treatment,” said Nancy Mantell, co-founder of Curident and a South Florida resident. “Oral care becomes incredibly difficult during treatment, yet it remains critically important. With the guidance of chemists, dental, and medical professionals, we created Curident to make that process easier, safer, and more soothing - for patients and for the professionals who care for them.”

Experience Curident at ONS Congress 2026

Healthcare professionals attending the ONS Congress in San Antonio, TX (May 13-17) can visit Booth 448 for product demonstrations, clinical discussions, and partnership opportunities. At the conference, Curident representatives will be available to discuss:

• Integration into oncology care protocols
• Distribution opportunities for treatment centers and healthcare providers
• The company’s Care + Giving Program, supporting patients in need.

Media & Professional Inquiries

For more information, partnership opportunities, or media requests, please contact: [email protected].

Curident is not intended to diagnose, treat, cure, or prevent any disease.